Changes in Chromogranin A Serum Levels During Endocrine Therapy in Metastatic Prostate Cancer Patients

Prognostic factors in prostate cancer. College of American Pathologists Consensus Statement 1999.

PubMed · 2000 · 1.2K citations

Reduced infiltration of tumor-associated macrophages in human prostate cancer: association with cancer progression.

Satoru Shimura, Guang Yang, Shin Ebara et al. · PubMed · 2000 · 274 citations

Tumor-associated Macrophages, Immunology, Immunoediting +16

Terminal neuroendocrine differentiation of human prostate carcinoma cells in response to increased intracellular cyclic AMP.

Yung‐Jue Bang, Farzaneh Pirnia, Wen‐Ning Fang et al. · Proceedings of the National Academy of Sciences · 1994 · 246 citations

Urology, Developmental Biology, Signal Transduction +13

The course of neuroendocrine differentiation in prostatic carcinomas

Per‐Anders Abrahamsson, Sture Falkmer, K Fält et al. · Pathology - Research and Practice · 1989 · 190 citations

Urology, Prostatic Carcinomas, Benign Prostatic Hyperplasia +5

Endocrine-paracrine cell types in the prostate and prostatic adenocarcinoma are postmitotic cells*1

Helmut Bonkhoff · Human Pathology · 1995 · 176 citations

Urology, Prostatic Adenocarcinoma, Postmitotic Cells +7